Company / Capital Returned to Shareholders per Share
Emergent BioSolutions Inc. Capital Returned to Shareholders per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Returned to Shareholders per Share
$0.48
FY2025
5-year range
$0.00 / $2.07
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#33 of 51
Health Care
What the data says
At $0.48, Emergent BioSolutions Inc.'s capital returned to shareholders per share ranks #33 of 51 in the Health Care sector. Improved from $0.00 to $0.48 over the past 2 years.
Based on SEC 10-K filings.
0.48 in FY2025 with a 3-year CAGR of -33.2%.
Improved from $0.00 to $0.48 over the past 2 years.
Health Care sector context is included.
Capital Returned to Shareholders per Share over time
Growth rates
- 3-Year CAGR
- -33.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#33 of 51 in Health CareTop 65% of 51This company $0.48 Sector average $2.74
▼
-82.5% below sector average
Key checks
Key Insights
- Ranks #33 out of 51 companies in the Health Care sector.
- Peak capital returned to shareholders per share was recorded in FY2021.
- Lowest capital returned to shareholders per share in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital Returned to Shareholders per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.48 | - |
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $1.60 | -22.5% |
| FY2021 | $2.07 | - |
| FY2020 | $0.00 | - |
| FY2019 | $0.00 | - |
| FY2018 | $0.00 | -100.0% |
| FY2017 | $0.82 | - |
| FY2016 | $0.00 | -100.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026